APP and Alzheimer disease: A study on the treatment of AD has shown that acute blockade of the TRPA1 channel with HC030031 (5 mg/kg body weight) restores the astrocyte activity to physiological levels, and can completely reverse early neuronal over-activity in a 1-month-old APP/PS1-21 mouse model of AD [63] (Figure 3).